Bowel Diseases, Inflammatory
10
0
0
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
20.0%
2 terminated out of 10 trials
75.0%
-11.5% vs benchmark
30%
3 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Use of Dexmedetomidine to Improve Pain Control and Recovery After Laparocopic-Assisted Bowel Surgery in Adults
LuCID - Investigating the Use of a Novel Digital Rectoscope for Community Examinations During COVID-19
Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD
Tofacitinib Registry of Patients With Ulcerative Colitis in Germany
Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole
TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
Anti-TNF Therapy for Refractory Colitis in Hospitalized Children
Bmgim Music Therapy Method in Reducing Stress in Patients With Inflammatory Bowel Disease
Anemia in Inflammatory Bowel Disease